72 related articles for article (PubMed ID: 1688361)
1. Acute lymphoblastic leukemia (ALL) and cancer procoagulant activity.
Pogliani EM; Lanzafame C; Bucciarelli P; Corneo G
Haematologica; 1991; 76(6):526-7. PubMed ID: 1688361
[No Abstract] [Full Text] [Related]
2. The diagnostic approach to mediastinal masses.
Koduri PR
Ann Thorac Surg; 2004 Nov; 78(5):1888; author reply 1888. PubMed ID: 15511522
[No Abstract] [Full Text] [Related]
3. [Cancer procoagulant--biochemical characteristics and the influence on the development of neoplastic disease].
Kamocka M; Mielicki WP
Postepy Biochem; 2003; 49(3):168-74. PubMed ID: 15083609
[No Abstract] [Full Text] [Related]
4. [Diagnostic significance of cancer procoagulant activity in colorectal cancer].
Kozuszko B; Skrzydlewski Z; Famulski W
Pol Merkur Lekarski; 2000 Mar; 8(45):127-8. PubMed ID: 10870414
[TBL] [Abstract][Full Text] [Related]
5. [Usefulness of detecting cancer procoagulant activity and thyrotropic hormone concentration in the differentiation of tumor-like changes in the thyroid].
Snarska J; Szajda SD; Knaś M; Mroczko B; Borzym-Kluczyk M; Kamiński F; Zwierz P; Zwierz K
Wiad Lek; 2006; 59(5-6):332-5. PubMed ID: 17017477
[TBL] [Abstract][Full Text] [Related]
6. Correspondence re: R. Varon et al., Mutations in the Nijmegen breakage syndrome gene (NBS1) in childhood acute lymphoblastic leukemia. Cancer Res., 61: 3570-3572, 2001.
Taylor GM; O'Brien HP; Greaves MF; Ravetto PF; Eden OB
Cancer Res; 2003 Oct; 63(19):6563-4; author reply 6565. PubMed ID: 14559852
[No Abstract] [Full Text] [Related]
7. WT1 protein expression in childhood acute leukemia.
Kerst G; Bergold N; Gieseke F; Coustan-Smith E; Lang P; Kalinova M; Handgretinger R; Trka J; Müller I
Am J Hematol; 2008 May; 83(5):382-6. PubMed ID: 18161786
[TBL] [Abstract][Full Text] [Related]
8. Serum levels of tumor necrosis factor and soluble interleukin 2 receptor as markers of disease activity and prognosis in childhood leukemia and lymphoma.
Kalmanti M; Karamolengou K; Dimitriou H; Tosca A; Vlachonikolis I; Peraki M; Georgoulias V; Kalmantis T
Int J Hematol; 1993 Apr; 57(2):147-52. PubMed ID: 8494993
[TBL] [Abstract][Full Text] [Related]
9. Serum lactate dehydrogenase is an important risk determinant in acute lymphocytic leukemia.
Fanin R; Zuffa E; Fasola G; Damiani D; Gallizia C; Michieli MG; Marcuzzi P; Russo D; Visani G; Resegotti L
Haematologica; 1989; 74(2):161-5. PubMed ID: 2501169
[TBL] [Abstract][Full Text] [Related]
10. [Cancer procoagulant and cathepsin D activity in blood serum in patients with bladder cancer].
Szajda SD; Darewicz B; Kudelski J; Chlabicz M; Domel T; Chabielska E; Skrzydlewski Z
Pol Merkur Lekarski; 2005 Jun; 18(108):651-3. PubMed ID: 16124376
[TBL] [Abstract][Full Text] [Related]
11. [Clinical significance of the detection of the sL-selectin level in patients with acute leukemia].
Chang JH; Qi ZH; Xu M
Hunan Yi Ke Da Xue Xue Bao; 2002 Apr; 27(2):151-3. PubMed ID: 12575346
[TBL] [Abstract][Full Text] [Related]
12. Serum levels of sCD137 (4-1BB) ligand are prognostic factors for progression in acute myeloid leukemia but not in non-Hodgkin's lymphoma.
Hentschel N; Krusch M; Kiener PA; Kolb HJ; Salih HR; Schmetzer HM
Eur J Haematol; 2006 Aug; 77(2):91-101. PubMed ID: 16800841
[TBL] [Abstract][Full Text] [Related]
13. Terminal deoxynucleotidyl transferase staining of malignant lymphomas in paraffin sections: a useful method for the diagnosis of lymphoblastic lymphoma.
Suzumiya J; Ohshima K; Kikuchi M; Takeshita M; Akamatsu M; Tashiro K
J Pathol; 1997 May; 182(1):86-91. PubMed ID: 9227346
[TBL] [Abstract][Full Text] [Related]
14. Clinical implications of telomerase activity levels in acute leukemia.
Ohyashiki JH; Ohyashiki K; Iwama H; Hayashi S; Toyama K; Shay JW
Clin Cancer Res; 1997 Apr; 3(4):619-25. PubMed ID: 9815729
[TBL] [Abstract][Full Text] [Related]
15. [Correlation of immunophenotypes with chromosomal findings in acute lymphoblastic leukemia].
Nakamura H; Sadamori N; Sasagawa I; Itoyama T; Yao E; Tomonaga M; Ichimaru M; Okamoto S; Watanabe T; Kinoshita K
Rinsho Ketsueki; 1988 Aug; 29(8):1219-26. PubMed ID: 3204673
[No Abstract] [Full Text] [Related]
16. Immunophenotypic characteristics of T-acute lymphoblastic leukemia cells in relation to DPP IV enzyme expression.
Klobusická M; Babusíková O
Neoplasma; 1998; 45(4):237-42. PubMed ID: 9890667
[TBL] [Abstract][Full Text] [Related]
17. Expression of gene encoding P65 oncofetal protein in acute and chronic leukemias.
Balcerczak E; Bartkowiak J; Błoński JZ; Robak T; Mirowski M
Neoplasma; 2002; 49(5):295-9. PubMed ID: 12458326
[TBL] [Abstract][Full Text] [Related]
18. Impact of genotype on survival of children with T-cell acute lymphoblastic leukemia treated according to the French protocol FRALLE-93: the effect of TLX3/HOX11L2 gene expression on outcome.
Ballerini P; Landman-Parker J; Cayuela JM; Asnafi V; Labopin M; Gandemer V; Perel Y; Michel G; Leblanc T; Schmitt C; Fasola S; Hagemejier A; Sigaux F; Auclerc MF; Douay L; Leverger G; Baruchel A
Haematologica; 2008 Nov; 93(11):1658-65. PubMed ID: 18835836
[TBL] [Abstract][Full Text] [Related]
19. [Use of monoclonal antibodies in acute lymphoblastic leukemia in children. I. Immunological subclassification of acute lymphoblastic leukemia].
Pediatr Pol; ; . PubMed ID: 3253655
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
